Goodrx Holdings Stock News

Wednesday''s top analyst upgrades and downgrades included Allstate, Arista Networks, Comcast, DraftKings, GoodRx, Kroger, Live Nation Entertainment, Luminar Technologies, Snap, Sunstone Hotel Investors, Twitter, Voya Financial, Vroom, Waste Management, Workday, Zoom Video Communications.

Travel stocks fell as Ukraine crisis sends oil prices higher. Higher crude pushed CVX to a new high. JPM dropped to a new low. GDRX plunged on earnings news. TASK rose on quarterly results.

Discount drug prescription site GoodRx plunged 39% after the company missed estimates on revenue and gave a weak forecast.

Shares of GoodRx (GDRX) have continued to fall today after reporting its Q4 2021 results after the closing bell Monday and soft guidance.

Consumer-focused digital healthcare, GoodRx Holdings Inc (NASDAQ: GDRX ) shares are plunging after the company''s Q4 FY21 earnings came in below expectations . Several analysts have downgraded the stock with reduced price targets in reaction to the earnings. SVB Leerink maintains GoodRx with an Outperform and lowers the price target from $49 to $33. Goldman Sachs maintains GoodRx with a Buy with a price target of $30, down from $43. RBC Capital maintains GoodRx with an Outperform and price target … Full story available on Benzinga.com

U.S. stocks remained lower midway through trading on Tuesday, amid the ongoing Russia-Ukraine conflict. The Dow traded down 1.17% to 33,497.30 while the NASDAQ fell 0.40% to 13,696.04. The S&P also fell, dropping, 0.74% to 4,341.75. Check out this: Insiders Buy Around $98M Of 3 Stocks Leading and Lagging Sectors Energy shares climbed by 0.9% on Tuesday. Meanwhile, top gainers in the sector included New Fortress Energy Inc. (NYSE: NFE ), up 14% and North European Oil Royalty Trust (NYSE: NRT ) up 10%. In trading on Tuesday, energy shares fell by 2.8%. Top Headline Target Corporation (NYSE: TGT ) reported better-than-expected earnings for its fourth quarter, while sales missed estimates. Target posted quarterly earnings of $3.19 per share, beating analysts’ estimates of $2.86 per share. The company’s quarterly sales came in at 31.00 billion, missing expectations of $31.41 billion. Target said it sees low-to-mid single digit revenue growth for 2022. Equities Trading UP iQIYI, Inc. (NASDAQ: IQ ) shares shot up 30% to $5.39 after the company reported fourth-quarter FY21 revenue of $1.2 billion, flat year-on-year, beating the consensus of $1.15 billion.

Tuesday afternoon''s top analyst upgrades and downgrades included Charter Communications, Comcast, Farfetch, GoodRx, Lincoln National and Vroom.

GoodRx Holdings Inc (NASDAQ: GDRX ) is plunging Tuesday after the company reported worse-than-expected fourth-quarter financial results and issued guidance below estimates. Latest … Full story available on Benzinga.com

Prescription drug price-comparison tool GoodRx is suffering major losses today. GDRX is down big after failing to beat earnings estimates.

NEW YORK , March 1, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LCID, SOFI, VALE, IQ, and GDRX. … Full story available on Benzinga.com

GoodRx Plunges 35% As Guidance Disappoints

CTI BioPharma CTIC +40%. Oak Street Health (OSH) +23%. AVITA Medical (RCEL) +15%. GoodRx Holdings GDRX -40%. Semler Scientific (SMLR) -30%.

Consumer-focused digital healthcare, GoodRx Holdings Inc (NASDAQ: GDRX) shares are plunging after the company's Q4 FY21 earnings came in below expectations. Several analysts have downgraded the s

Prescription drug price-comparison tool GoodRx is suffering major losses today. GDRX is down big after failing to beat earnings estimates.